标题
Cardiometabolic Effects of Anti-obesity Pharmacotherapy
作者
关键词
Obesity, Metabolic syndrome, Weight loss medications, Heart disease
出版物
Current Atherosclerosis Reports
Volume 20, Issue 4, Pages -
出版商
Springer Nature
发表日期
2018-03-06
DOI
10.1007/s11883-018-0719-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis
- (2017) Christina N Katsagoni et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Mechanisms, Pathophysiology, and Management of Obesity
- (2017) Steven B. Heymsfield et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients
- (2017) Rashid Ali Khan et al. Therapeutics and Clinical Risk Management
- Improvement of plasma adiponectin, leptin and C-reactive protein concentrations by orlistat: a systematic review and meta-analysis
- (2016) Giuseppe Derosa et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s
- (2016) Catherine E. Thomas et al. Obesity
- Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist
- (2016) Kenichi Katsurada et al. Journal of Diabetes Investigation
- Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
- (2015) J. E. Hall et al. CIRCULATION RESEARCH
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adipose tissue as an immunological organ
- (2015) Ryan W. Grant et al. Obesity
- Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
- (2014) Francisco Kerr Saraiva et al. Cardiovascular Diabetology
- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
- (2014) Philip R. Schauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial
- (2013) Steven P. Marso et al. AMERICAN HEART JOURNAL
- Control of hypertension with medication: a comparative analysis of national surveys in 20 countries
- (2013) Nayu Ikeda et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Mechanisms and Metabolic Implications of Regional Differences among Fat Depots
- (2013) Tamara Tchkonia et al. Cell Metabolism
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association
- (2013) Harold E. Bays et al. Journal of Clinical Lipidology
- Do Lifestyle Changes Reduce Serious Outcomes in Diabetes?
- (2013) Hertzel C. Gerstein NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Use of Prescription Antiobesity Drugs in the United States
- (2013) Christian Hampp et al. PHARMACOTHERAPY
- Management of Obesity in the National Health and Nutrition Examination Survey (NHANES), 2007–2008
- (2012) Nithushi R. Samaranayake et al. ANNALS OF EPIDEMIOLOGY
- Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
- (2012) Patrick M. O'Neil et al. Obesity
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
- (2011) Michael R. Charlton et al. GASTROENTEROLOGY
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- The Human Plasma Lipidome
- (2011) Oswald Quehenberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change: From the Look AHEAD (Action for Health in Diabetes) study
- (2010) L. M. Belalcazar et al. DIABETES CARE
- Prevalence and Trends in Obesity Among US Adults, 1999-2008
- (2010) Katherine M. Flegal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Metabolic Syndrome and Cardiovascular Risk
- (2010) Salvatore Mottillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial
- (2008) Stephen A. Harrison et al. HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started